NCT05530226

A Single Arm Study of Traditional Chinese Medicine for Plasma Cell Mastitis

A Single Arm Study of Traditional Chinese Medicine for Treatment of Plasma Cell Mastitis

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Shengjing Hospital · Academic / Other
• Sex: Female
• Age: 20 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

This is a single-center, single-arm, open-label trial evaluating the efficacy and safety of traditional Chinese medicine for plasma cell mastitis.

Detailed description

This is a single-center, single-arm, open-label trial evaluating the efficacy and safety of traditional Chinese medicine for plasma cell mastitis. This study will include 50 patients with plasma cell mastitis. After providing written informed consent, the participants will receive traditional herbal medicine twice daily. Efficacy will be assessed every 15 days. If the disease progresses, the participant will withdraw from the trial.

Conditions

• Plasma Cell Mastitis

Interventions

Type	Name	Description
DRUG	Traditional Chinese medicine	Traditional Chinese medicine, oral administration, twice daily

Timeline

• Start date: 2021-10-01
• Primary completion: 2022-10-31
• Completion: 2023-03-31
• First posted: 2022-09-07
• Last updated: 2022-09-07

Locations

1 site across 1 country: China